New look
Same products you know and trust
BD pen needles and insulin syringes are now part of embecta, a global diabetes care company.
LEARN MOREWe take diabetes personally
For us, supporting people with diabetes is deeply personal. The millions of people worldwide living with diabetes are our friends, our loved ones, our colleagues — and even ourselves.
VIEW STORIESEmpowered by 100 years of innovation we are focused on supporting people with diabetes1§
We are driven by our mission to develop and provide solutions that support people with diabetes.
From the very beginning, we have advanced innovation in insulin delivery to support the injection experience.1-3§
Learn about our productsWe're with you at every step
We are committed to helping you inject correctly with access to education and resources on proper injection technique.
Explore injection technique resourcesAdvance every daytogetherTM
§Since the creation of the first BD insulin syringe in 1924.
References
1. Kesavadev J, Saboo B, Krishna MB, Krishnan G. Evolution of Insulin Delivery Devices: From Syringes, Pens, and Pumps to DIY Artificial Pancreas. Diabetes Ther. 2020;11(6):1251-1269. doi:10.1007/s13300-020-00831-z.
2. Aronson R, Gibney MA, Oza K, et al. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings. Clin Ther. 2013;35(7):923-933.
3. Hirsch L, Gibney M, Berube J, Manocchio J. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes. J Diabetes Sci Technol. 2012;6(2):328-335. 2017.